Skip to main content

Advertisement

Log in

Metabolomic profiling for identification of potential biomarkers in patients with dermatomyositis

  • Original Article
  • Published:
Metabolomics Aims and scope Submit manuscript

Abstract

Introduction

Dermatomyositis (DM) is a rare autoimmune myopathy characterized by skin lesions, proximal muscle weakness and muscle inflammation. The pathogenesis of DM is unclear, and identification of reliable biomarkers for early diagnosis of DM is critical for design of a specific therapy for this disease.

Objectives

To find and identify potential serum biomarkers in DM patients.

Methods

We performed an untargeted metabolomic approach using UHPLC-MS/MS. The blood serum metabolomic profiles of 26 DM patients and 26 healthy controls were collected. Multivariate analysis of the metabolomic profile was applied to differentiate DM patients and controls and to find potential biomarkers.

Results

A significantly disturbed metabolic profile of DM patients was observed. Pathway analysis showed that aminoacyl-tRNA biosynthesis, phenylalanine, tyrosine and tryptophan biosynthesis, and nitrogen metabolism are the most prominently altered pathways in DM. Receiver operating characteristic curve indicated that glutamine, methionine, isoleucine, tryptophan, glutamic acid, indole, protocatechuic acid, and phenylalanine were potential biomarkers for DM diagnosis in terms of both sensitivity and specificity.

Conclusions

Our study provides new insight into underlying mechanisms of DM, and we suggest that we should pay more attention to these metabolic pathways in the prevention and treatment of DM.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  • Bendewald, M. J., Wetter, D. A., Li, X., et al. (2010). Incidence of dermatomyositis and clinically amyopathic dermatomyositis: A population-based study in Olmsted County, Minnesota. Archives of Dermatology, 146, 26–30.

    Article  Google Scholar 

  • Bernatsky, S., Joseph, L., Pineau, C. A., et al. (2009). Estimating the prevalence of polymyositis and dermatomyositis from administrative data: Age, sex and regional differences. Annals of the Rheumatic Diseases, 68, 1192–1196.

    Article  CAS  Google Scholar 

  • Bohan, A., & Peter, J. B. (1975a). Polymyositis and dermatomyositis (first of two parts). New England Journal of Medicine, 292, 344–347.

    Article  CAS  Google Scholar 

  • Bohan, A., & Peter, J. B. (1975b). Polymyositis and dermatomyositis (second of two parts). New England Journal of Medicine, 292, 403–407.

    Article  CAS  Google Scholar 

  • Cooper, G. S., & Stroehla, B. C. (2003). The epidemiology of autoimmune diseases. Autoimmunity Reviews, 2, 119–125.

    Article  Google Scholar 

  • Dalakas, M. C. (1991). Polymyositis, dermatomyositis and inclusion-body myositis. New England Journal of Medicine, 325, 1487–1498.

    Article  CAS  Google Scholar 

  • Dalakas, M. C., & Hohlfeld, R. (2003). Polymyositis and dermatomyositis. Lancet, 362, 971–982.

    Article  CAS  Google Scholar 

  • Eisenberg, D., Almassy, R. J., Janson, C. A., et al. (1987). Some evolutionary relationships of the primary biological catalysts glutamine synthetase and RuBisCO. Cold Spring Harbor Symposia on Quantitative Biology, 52, 483–490.

    Article  CAS  Google Scholar 

  • Gostner, J. M., Becker, K., Kofler, H., et al. (2016). Tryptophan metabolism in allergic disorders. International Archives of Allergy and Immunology, 169, 203–215.

    Article  CAS  Google Scholar 

  • Lai, H. S., Lee, J. C., Lee, P. H., et al. (2005). Plasma free amino acid profile in cancer patients. Seminars in Cancer Biology, 15, 267–276.

    Article  CAS  Google Scholar 

  • Liaw, S. H., Pan, C., & Eisenberg, D. (1993). Feedback inhibition of fully unadenylylated glutamine synthetase from Salmonella typhimurium by glycine, alanine, and serine. Proc Natl Acad Sci USA, 90, 4996–5000.

    Article  CAS  Google Scholar 

  • Lichter-Konecki, U., Hipke, C., & Konecki, D. (1999). Human phenylalanine hydroxylase gene expression in kidney and other nonhepatic tissues. Molecular Genetics and Metabolism, 316, 308–316.

    Article  Google Scholar 

  • Liesenfeld, D. B., Habermann, N., Owen, R. W., et al. (2013). Review of mass spectrometry-based metabolomics in cancer research. Cancer Epidemiology, Biomarkers and Prevention, 22, 2182–2201.

    Article  CAS  Google Scholar 

  • Mainetti, C., Terziroli Beretta-Piccoli, B., & Selmi, C. (2017). Cutaneous manifestations of dermatomyositis: A comprehensive review. Clinical Reviews in Allergy and Immunology, 53, 337–356.

    Article  Google Scholar 

  • Neurauter, G., Grahmann, A. V., Klieber, M., et al. (2008). Serum phenylalanine concentrations in patients with ovarian carcinoma correlate with concentrations of immune activation markers and of isoprostane-8. Cancer Letters, 272, 141–147.

    Article  CAS  Google Scholar 

  • Olazagasti, J. M., Baez, P. J., Wetter, D. A., et al. (2015). Cancer risk in dermatomyositis: A meta-analysis of cohort studies. American Journal of Clinical Dermatology, 16, 89–98.

    Article  Google Scholar 

  • Palego, L., Betti, L., Rossi, A., et al. (2016). Tryptophan biochemistry: Structural, nutritional, metabolic, and medical aspects in humans. Journal of Amino Acids, 2016, 8952520.

    Article  Google Scholar 

  • Palmieri, E. M., Spera, I., Menga, A., et al. (2014). Glutamine synthetase desensitizes differentiated adipocytes to proinflammatory stimuli by raising intracellular glutamine levels. FEBS Letters, 588, 4807–4814.

    Article  CAS  Google Scholar 

  • Plotz, P. H., Dalakas, M., Leff, R. L., et al. (1989). Current concepts in the idiopathic inflammatory myopathies: Polymyositis, dermatomyositis, and related disorders. Annals of Internal Medicine, 111, 143–157.

    Article  CAS  Google Scholar 

  • Rabinowitz, J. D., Purdy, J. G., Vastag, L., et al. (2011). Metabolomics in drug target discovery. Cold Spring Harbor Symposia on Quantitative Biology, 76, 235–246.

    Article  CAS  Google Scholar 

  • Schnackenberg, L. K. (2007). Global metabolic profiling and its role in systems biology to advance personalized medicine in the 21st century. Expert Review of Molecular Diagnostics, 7, 247–259.

    Article  CAS  Google Scholar 

  • Tolstikov, V. (2016). Metabolomics: Bridging the gap between pharmaceutical development and population health. Metabolites, 6, E20.

    Article  Google Scholar 

  • Tsugawa, H., Cajka, T., Kind, T., et al. (2015). MS-DIAL: Data-independent MS/MS deconvolution for comprehensive metabolome analysis. Nature Methods, 12, 523–526.

    Article  CAS  Google Scholar 

  • Xia, J., Psychogios, N., Young, N., et al. (2009). MetaboAnalyst: A web server for metabolomic data analysis and interpretation. Nucleic Acids Research, 37, W652–660.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank all participants in this study and the clinical doctors from the China-Japan Friendship Hospital for collection of samples. This work was supported by the National Natural Science Foundation of China (Grants 81301801 and 81430056), Science and Technology Planning Project of Chaoyang District, Beijing (CYSF1835), R&D Infrastructure and Facility Development Program of Fujian (2018H2002), Industry University Research Project of Fujian (2018H6101), and the National Health and Family Planning Commission of the People’s Republic of China (Grant W2015CAE016).

Author information

Authors and Affiliations

Authors

Contributions

TZ and JX provided and pretreated the samples; JL performed the LC-MS analysis; JL and YL performed the data analysis and co-wrote the paper. All authors read and approved the manuscript.

Corresponding authors

Correspondence to Yang Liu or Jia Liu.

Ethics declarations

Conflicts of interest

The authors declare no conflict of interest.

Ethical approval

This study was approved by the Ethics Committee of the China-Japan Friendship Hospital.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 236 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Zhang, T., Xu, J., Liu, Y. et al. Metabolomic profiling for identification of potential biomarkers in patients with dermatomyositis. Metabolomics 15, 77 (2019). https://doi.org/10.1007/s11306-019-1539-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11306-019-1539-9

Keywords

Navigation